DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Henderson IC, Berry D, Demetri G, Cirrincione C. et al.
Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients (pts) with node-positive primary breast cancer (BC).
Proc ASCO 1998; 17: 390 A (abstract)
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.